Skip to main content
User Image

Rukhsana Gul

Associate Professor

Ph.D

College of Medicine and University Hospitals
College of Medicine, King Saud University

announcement

announcement

Dr. Gul is currently open to mentoring Master's and Ph.D. students in the field of biological…

introduction/brief CV

Dr. Rukhsana Gul is a Principal Investigator and Associate Professor at the Obesity Research Center, College of Medicine, King Saud University, Riyadh, Saudi Arabia. She is a cardiovascular scientist with expertise in cell signaling, molecular biology, cardiovascular pharmacology, and nanomedicine. Dr. Gul earned her Ph.D. in Medicine from Jeonbuk National University, South Korea. She pursued postdoctoral research training at Chonbuk National University, South Korea, and the University of Missouri, USA. Her research has contributed to the understanding of angiotensin II-mediated cardiovascular signaling, β-adrenergic receptor biology, oxidative stress, mitochondrial dysfunction, and cardiac injury, leading to the identification of novel therapeutic targets and strategies for cardiovascular disease.Her current research focuses on the molecular mechanisms linking metabolic disorders and cardiovascular disease, with particular emphasis on metabolic syndrome, mitochondrial dysfunction, cardiac hypertrophy, fibrosis, and cardiovascular injury. Her laboratory investigates the therapeutic potential of β-adrenergic receptor blockers, nanoceria and other nanomaterials, alongside molecular and proteomic approaches to identify novel mechanisms and therapeutic targets. In recognition of her research contributions, Dr. Gul has been the recipient of numerous distinguished awards including Best Dissertation Award from Jeonbuk National University, Young Scientist Award, Young Investigator Award from Veterans Affairs, University of Missouri and outstanding research in her doctoral and postdoctoral training. She has also been awarded competitive research funding and has presented her work at international scientific conferences. Dr. Gul aims to improve the understanding of cardiovascular complications associated with metabolic diseases and to contribute to the development of innovative treatments through an interdisciplinary research program integrating cardiovascular biology, metabolic research, pharmacology, nanotechnology and omics approaches.


 

areas of expertise

  • Cardiovascular Disease and Cardiometabolic Research
    Cardiovascular Cell Signaling
    Renin–Angiotensin–Aldosterone System (RAAS)
    β-Adrenergic Receptor Signaling and Pharmacology
    Obesity and Metabolic Disorders
    Mitochondrial Dysfunction and Oxidative Stress
    Cardiac Hypertrophy and Myocardial Injury
    Nanomedicine and Nanomaterials
    Nanoceria and Nanozyme-Based Therapeutics
    Proteomics and Molecular Profiling
    Cardiovascular Pharmacology
    Type 2 Diabetes and Cardiovascular Complications
    Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)